IVERIC bio (ISEE) Reports In-Line Q1 EPS

IVERIC bio (NASDAQ: ISEE) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Yext, Inc. (YEXT) Tops Q2 EPS by 4c
• Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick